Repository logo
 

Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Antiviral signaling, immune response and cell metabolism are dysregulated by SARS-CoV-2, the causative agent of COVID-19. Here, we show that SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10 induce a significant mitochondrial and metabolic reprogramming in A549 lung epithelial cells. While ORF9b, ORF9c and ORF10 induced largely overlapping transcriptomes, ORF3a induced a distinct transcriptome, including the downregulation of numerous genes with critical roles in mitochondrial function and morphology. On the other hand, all four ORFs altered mitochondrial dynamics and function, but only ORF3a and ORF9c induced a marked alteration in mitochondrial cristae structure. Genome-Scale Metabolic Models identified both metabolic flux reprogramming features both shared across all accessory proteins and specific for each accessory protein. Notably, a downregulated amino acid metabolism was observed in ORF9b, ORF9c and ORF10, while an upregulated lipid metabolism was distinctly induced by ORF3a. These findings reveal metabolic dependencies and vulnerabilities prompted by SARS-CoV-2 accessory proteins that may be exploited to identify new targets for intervention.

Description

Publication status: Published


Funder: ICREA foundation (ICREA‐Academia‐2021 to MC) of Generalitat de Catalunya


Funder: Serra Húnter Fellow


Funder: Ramón y Cajal contract

Journal Title

J Med Virol

Conference Name

Journal ISSN

0146-6615
1096-9071

Volume Title

96

Publisher

Wiley

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsorship
Spanish Ministry of Science project (PID2021‐123399OB‐I00)
Agency for Management of University and Research Grants from Generalitat de Catalunya‐AGAUR (2020PANDE00048, 2021SGR00350)
AESi grant of the Instituto de Salud Carlos III (PI20CIII‐00014)
CSIC's Global Health Platform (PTI+ Salud Global) (COVID‐19‐117, SGL2103015)
Junta de Andalucía (CV20‐20089)